Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
Key Points
Large, sudden stock price swings—like Medpace’s recent spike and drop—are often driven by identifiable factors such as short squeezes or concentrated trading, not pure randomness.
Investors should distinguish between moves based on verifiable corporate developments and those fueled by momentum or retail trading, as each carries different risks and implications for long-term value.
- 10 stocks we like better than Medpace ›
Discover what drives dramatic price swings in stocks like Medpace (NASDAQ: MEDP) and how market mechanics, not just news, can shape outcomes. Watch the video below to learn how investors can navigate these volatile moves.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Should you buy stock in Medpace right now?
Before you buy stock in Medpace, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Medpace wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $414,554!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,120,663!*
Now, it’s worth noting Stock Advisor’s total average return is 884% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of February 16, 2026.
Jason Hall has no position in any of the stocks mentioned. Lou Whiteman has no position in any of the stocks mentioned. Toby Bordelon has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Medpace. The Motley Fool has a disclosure policy.
Recommended Articles
